Monogram Health is a leading renal disease care management company providing an innovative care model and data-driven solutions to transform care for patients living with chronic kidney and end-stage renal disease.
Monogram Health is dedicated to improving the well being, quality of life and health outcomes for our patients by partnering with the nation's leading kidney specialists to provide transformative kidney care.
Monogram Health was founded in 2019 by Mike Uchrin and Christopher A. Booker. The company is headquartered in Nashville, Tennessee.
Monogram Health supports patients suffering from Chronic Kidney Disease by forming deep rooted relationships and preparing them both emotionally and physically for the challenges of managing Kidney Disease.
Monogram Health uses next generation artificial intelligence algorithms to predict necessary and timely care to promote the delay of Kidney Disease progression, seamless transitions to dialysis and/or pre-emptive kidney transplant, as well as to optimize our patients’ health outcomes once on dialysis.
Monogram Health partners with health plans to collaborate with nephrologists and ensure high-quality patient care is delivered cost effectively. Monogram’s care management team of nurses, social workers, nephrologists, and geriatricians develop strong and lasting relationships with patients through in-person visits to their homes.
Monogram Health is backed by Frist Cressey Ventures and Norwest Venture Partners. The company raised $7M in a Series A-1 financing round on May 05, 2020. This brings Monogram Health's total funding to $12M to date.